| 30 sept. 2009 |
Raport Concurenta: Piata produselor alimentare s-a cifrat la 14,6 mld. euro in 2008 |
| 29 sept. 2009 |
A&D Pharma confirms Ozone acquisition talks |
| 29 sept. 2009 |
A&D Pharma confirma ca se afla in negocieri pentru preluarea filialelor Ozone din ECE |
| 29 sept. 2009 |
CNAS vrea 2,8 mld. lei pentru finantarea sectorului sanatatii in T4 |
| 28 sept. 2009 |
Criza a redus preturile la Mega Image cu 15% |
| 25 sept. 2009 |
Ewopharma Romania, scadere a profitabilitatii pana la 36% |
| 25 sept. 2009 |
Concurenta banuieste petrolistii ca s-au inteles la pret |
| 23 sept. 2009 |
Time to be my own boss: Advisory, the right medicine for pharma execs |
| 22 sept. 2009 |
A&D Pharma appoints new investor relations director |
| 18 sept. 2009 |
Sefa Farmec: Suntem in discutii si cu alte companii pentru furnizarea de produse sub marca proprie |
| 18 sept. 2009 |
Vascar si-a redus tinta de crestere pe 2009, pana la 20% |
| 18 sept. 2009 |
Dussaix, Carrefour Romania: Intr-un an am putea exporta produse romanesti sub marca privata |
| 15 sept. 2009 |
Scaderi pe toata linia in farma: minus de 15% in volum, respectiv minus 8,8% ca valoare in T2 |
| 14 sept. 2009 |
Remedia shelves Dornafarm bid |
| 14 sept. 2009 |
Million dollar German: Two hundred years from now and I would still invest in Romania |
| 14 sept. 2009 |
Remedia amana negocierile cu Dornafarm pana in 2010 |
| 11 sept. 2009 |
Lutz Stache investeste 40 mil. euro in fosta in fabrica de var a Mittal Galati |
| 10 sept. 2009 |
Mihail Marcu, MedLife: Jucatorii mici interesanti nu sunt de vanzare |
| 09 sept. 2009 |
Ozone-Advent deal under antitrust scrutiny |
| 08 sept. 2009 |
Solutie de criza: PIC inchiriaza 30% din parcarile magazinelor |
| 07 sept. 2009 |
Ruxandra Nastase says Ozone a closed chapter now |
| 07 sept. 2009 |
Ruxandra Nastase: Ozone este un capitol incheiat |
| 07 sept. 2009 |
Marius Chereches, recrutat de LaborMed |
| 03 sept. 2009 |
LaborMed tinteste 6% din piata produselor fitoterapeutice cu brandurile PlantExtrakt |
| 02 sept. 2009 |
Terapia to sell first drug under Ranbaxy and Daiichi Sankyo umbrella |
